AVAX Technologies, Inc. Share Price Other OTC
Equities
AVXT
US0534953056
Biotechnology & Medical Research
Sales 2009 | 399K 31.92M | Sales 2010 | 142K 11.39M | Capitalization | 6.29M 503M |
---|---|---|---|---|---|
Net income 2009 | -19M -1.52B | Net income 2010 | -12M -959M | EV / Sales 2009 | 69 x |
Net Debt 2009 | 3.23M 258M | Net Debt 2010 | 3.1M 248M | EV / Sales 2010 | 65.9 x |
P/E ratio 2009 |
-1.24
x | P/E ratio 2010 |
-1.03
x | Employees | - |
Yield 2009 * |
-
| Yield 2010 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Adele Sommerfeld
CEO | Chief Executive Officer | - | 18/10/15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew W. Dahl
CHM | Chairman | 79 | 31/08/99 |
Adele Sommerfeld
CEO | Chief Executive Officer | - | 18/10/15 |
Bruno Maruzzo
BRD | Director/Board Member | 71 | - |
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |